Want to see AMPH full AI Analyst Report?
Amphastar Pharmaceuticals (AMPH) Hedge Fund Trading Activity
Trend: ▼ Hedge Funds Decreased Holdings by 370.8K Shares Last Quarter
Hedge Fund Holdings in AMPH
Based on the 13F filings of 488 Hedge Funds submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
| Polaris Capital Management LLC | Not Changed | 0.00% | $872,422 | 0.08% | |||
| Gotham Asset Management LLC | Not Changed | 0.00% | $574,081 | <0.01% | |||
| Not Ranked | Reduced | -3.62% | $105,439,168 | 0.02% | |||
| Royce & Associates LLC | Reduced | -27.43% | $5,948,216 | 0.05% | |||
| Hussman Strategic Advisors Inc | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold Amphastar Pharmaceuticals?
The hedge funds that hold the most shares in Amphastar Pharmaceuticals are BlackRock, Inc., Bernard Horm and Chuck Royce.
Are hedge funds buying or selling AMPH?
In the last quarter hedge funds have Decreased their holdings in Amphastar Pharmaceuticals by 370.8K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Amphastar Pharmaceuticals stock?
Warren Buffet currently does not own shares in Amphastar Pharmaceuticals.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here